Haruo Iwabuchi
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Drug Transport and Resistance Mechanisms
Papers in
-
- Peroxisome Proliferator-Activated Receptors 7
- Metabolomics and Mass Spectrometry Studies 3
- Pharmacology 13
- Pharmacogenetics and Drug Metabolism 11
- Inflammatory mediators and NSAID effects 5
- Co-authors
- Toshihiko Ikeda (10 shared papers)K Nakamura (7 shared papers)Takahiro Murai (6 shared papers)Minoru Uchiyama (7 shared papers)TORU KOMAI (3 shared papers)Hidekuni Takahagi (3 shared papers)Tomoko Ikeda (3 shared papers)Akihiko Nakagawa (4 shared papers)
- Journals
- Drug Metabolism and Disposition (9 papers)Xenobiotica (3 papers)Drug Metabolism and Pharmacokinetics (2 papers)Biochemical and Biophysical Research Communications (1 paper)Tetrahedron (1 paper)
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Haruo Iwabuchi
34 papers receiving 556 citations
Peers
Comparison fields: 5 of 75
- Pharmacology 208
- Oncology 157
- Biochemistry 35
- Spectroscopy 63
- Analytical Chemistry 36
Countries citing papers authored by Haruo Iwabuchi
This map shows the geographic impact of Haruo Iwabuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruo Iwabuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruo Iwabuchi more than expected).
Fields of papers citing papers by Haruo Iwabuchi
This network shows the impact of papers produced by Haruo Iwabuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruo Iwabuchi. The network helps show where Haruo Iwabuchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Haruo Iwabuchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs. | 1997 | 88 |
| 2 | 2002 | 68 | |
| 3 | 1999 | 46 | |
| 4 | 2001 | 39 | |
| 5 | 1993 | 34 | |
| 6 | 1991 | 33 | |
| 7 | 2010 | 31 | |
| 8 | 2010 | 23 | |
| 9 | 2006 | 22 | |
| 10 | 2006 | 21 | |
| 11 | 1994 | 19 | |
| 12 | 2010 | 15 | |
| 13 | 2005 | 15 | |
| 14 | 1992 | 14 | |
| 15 | 1987 | 12 | |
| 16 | 2012 | 12 | |
| 17 | 1988 | 11 | |
| 18 | 2010 | 8 | |
| 19 | 2004 | 8 | |
| 20 | 2004 | 6 |
About Haruo Iwabuchi
Haruo Iwabuchi is a scholar working on Molecular Biology, Pharmacology, Oncology, Spectroscopy and Pharmacology, having authored 34 papers that have together received 577 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (8 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Analytical Chemistry and Chromatography (6 papers), Inflammatory mediators and NSAID effects (5 papers), Mass Spectrometry Techniques and Applications (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). The work is most often cited by research in Pharmacology (208 citations), Oncology (157 citations), Biochemistry (35 citations), Spectroscopy (63 citations) and Analytical Chemistry (36 citations). Haruo Iwabuchi has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Toshihiko Ikeda, K Nakamura, Takahiro Murai, Minoru Uchiyama, TORU KOMAI, Hidekuni Takahagi, Tomoko Ikeda, Akihiko Nakagawa, Hiroshi Yamazaki and Miki Nakajima. Their work appears in journals such as Drug Metabolism and Disposition, Xenobiotica, Drug Metabolism and Pharmacokinetics, Biochemical and Biophysical Research Communications and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.